Log in

NASDAQ:FLGTFulgent Genetics Stock Price, Forecast & News

$15.16
-0.39 (-2.51 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.14
Now: $15.16
$15.66
50-Day Range
$8.89
MA: $14.66
$17.06
52-Week Range
$5.09
Now: $15.16
$20.60
Volume221,054 shs
Average Volume362,529 shs
Market Capitalization$328.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Read More
Fulgent Genetics logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.53 million
Cash Flow$0.14 per share
Book Value$4.42 per share

Profitability

Net Income$-410,000.00

Miscellaneous

Employees123
Market Cap$328.94 million
Next Earnings Date8/3/2020 (Estimated)
OptionableNot Optionable

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

How has Fulgent Genetics' stock been impacted by COVID-19 (Coronavirus)?

Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, FLGT shares have increased by 50.7% and is now trading at $15.16. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Fulgent Genetics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fulgent Genetics.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Fulgent Genetics.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) issued its quarterly earnings data on Monday, May, 4th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.05. The firm had revenue of $7.75 million for the quarter, compared to analysts' expectations of $7.69 million. Fulgent Genetics had a negative net margin of 1.31% and a positive return on equity of 0.52%. View Fulgent Genetics' earnings history.

What price target have analysts set for FLGT?

4 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. Their forecasts range from $11.00 to $18.00. On average, they anticipate Fulgent Genetics' stock price to reach $13.08 in the next year. This suggests that the stock has a possible downside of 13.8%. View analysts' price targets for Fulgent Genetics.

Has Fulgent Genetics been receiving favorable news coverage?

Media headlines about FLGT stock have trended negative recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fulgent Genetics earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutFulgent Genetics.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a increase in short interest in May. As of May 15th, there was short interest totaling 768,900 shares, an increase of 30.1% from the April 30th total of 590,800 shares. Based on an average trading volume of 401,200 shares, the days-to-cover ratio is presently 1.9 days. Currently, 8.1% of the company's shares are sold short. View Fulgent Genetics' Current Options Chain.

Who are some of Fulgent Genetics' key competitors?

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include Crispr Therapeutics (CRSP), NVIDIA (NVDA), Inseego (INSG), InVitae (NVTA), Marvell Technology Group (MRVL), NeoGenomics (NEO), Alibaba Group (BABA), Baidu (BIDU), Editas Medicine (EDIT) and Bilibili (BILI).

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the following people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 63)
  • Mr. Paul Kim, Chief Financial Officer (Age 52)
  • Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 52)

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Driehaus Capital Management LLC (3.08%), Raymond James Trust N.A. (1.56%), Ranger Investment Management L.P. (1.51%), Hillsdale Investment Management Inc. (1.47%), Russell Investments Group Ltd. (1.32%) and Acadian Asset Management LLC (1.01%). Company insiders that own Fulgent Genetics stock include Ming Hsieh and Paul Kim. View institutional ownership trends for Fulgent Genetics.

Which institutional investors are selling Fulgent Genetics stock?

FLGT stock was sold by a variety of institutional investors in the last quarter, including Raymond James Trust N.A., Hillsdale Investment Management Inc., Essex Investment Management Co. LLC, Wedge Capital Management L L P NC, Alambic Investment Management L.P., EAM Investors LLC, Cornercap Investment Counsel Inc., and ClariVest Asset Management LLC. View insider buying and selling activity for Fulgent Genetics.

Which institutional investors are buying Fulgent Genetics stock?

FLGT stock was acquired by a variety of institutional investors in the last quarter, including Ranger Investment Management L.P., Russell Investments Group Ltd., Parametric Portfolio Associates LLC, Driehaus Capital Management LLC, Acadian Asset Management LLC, Bank of New York Mellon Corp, Morgan Stanley, and New York State Common Retirement Fund. View insider buying and selling activity for Fulgent Genetics.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $15.16.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $328.94 million and generates $32.53 million in revenue each year. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Fulgent Genetics employs 123 workers across the globe.

What is Fulgent Genetics' official website?

The official website for Fulgent Genetics is www.fulgentgenetics.com.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE SUITE 205, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.